Eylea Safety Versus Ease Of Reimbursement Frames Advisory Cmte. Discussion Of Dosing

FDA panel unanimously backs the wet age-related macular degeneration therapy with support for a bi-monthly dosing scheme, but monthly schedule may be included as well.